Continuing chemotherapy and immunotherapy treatment in cancer patients with Covid-19 is not a risk to their survival, a study suggests. It also recommends further research into the drug hydroxychloroquine, which appeared to benefit some patients. The findings, from 890 infected cancer patients in the UK, Spain, Italy and Germany, could help identify who is most… Read More: Chemotherapy in cancer patients with Covid-19 ‘not a risk’ »
Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More: Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in… »
Chemotherapy is a treatment that makes use of anti-cancer drugs to cure cancer cells. This process has been used for countless years. While it can be quite beneficial, it brings adverse reactions because chemotherapy medicines do not only reach cancer cells but also other areas of the body. These include fatigue, dry mouth, nerve changes,… Read More: How to Cope with Chemotherapy Side Effects »